Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions

Area of Science:

• Gerontology
• Muscle physiology
• Metabolic disorders

Background:

• Sarcopenia is age-related muscle wasting; cachexia is severe wasting linked to diseases like cancer.
• These conditions involve complex interactions between muscle and adipose tissue, with distinct underlying mechanisms.
• Conventional nutritional support is often insufficient for cachexia.

Purpose of the Study:

• To review the muscle microenvironment's role in sarcopenia and cachexia.
• To discuss current and emerging therapeutic strategies for these muscle-wasting conditions.
• To highlight the importance of understanding the interplay and distinctions between sarcopenia and cachexia for research and treatment.

Main Methods:

• Literature review of sarcopenia and cachexia pathogenesis.
• Analysis of therapeutic approaches including lifestyle, nutritional, and pharmacological interventions.
• Exploration of novel strategies like gene editing, stem cell therapy, and microbiome modulation.

Main Results:

• Muscle microenvironment alterations are central to both sarcopenia and cachexia.
• Multimodal interventions show promise for addressing these complex conditions.
• Emerging therapies offer new avenues for treatment development.

Conclusions:

• Distinguishing and understanding the mechanisms of sarcopenia and cachexia is crucial for advancing research.
• Innovative therapeutic strategies are needed to effectively manage these debilitating muscle-wasting syndromes.
• Further research into multimodal interventions can lead to improved patient outcomes.